Overview
Phosphorylated Rapamycin is a bioactive derivative of Rapamycin (Sirolimus), where phosphate groups are introduced to enhance its solubility and cellular uptake. This modification retains the parent compound's mTOR-inhibiting properties while improving pharmacokinetics. Primarily used in biomedical research, it has shown promise in targeted drug delivery systems and combination therapies. The compound emerged from efforts to overcome Rapamycin's limitations, such as poor water solubility and variable absorption. Its development reflects advances in prodrug design, particularly for immunosuppressive and anti-proliferative applications. Current research focuses on its potential in oncology and autoimmune disease treatment.
Physical and Chemical Properties
As a phosphorylated macrolide, this compound exhibits greater polarity than Rapamycin, influencing its dissolution profile. The added phosphate groups typically increase water solubility by 5–10 fold while maintaining lipid membrane permeability. Stability studies indicate sensitivity to hydrolysis at extreme pH (<3 or >9), requiring pH-neutral buffers for in vitro use. Spectroscopic characterization includes distinctive phosphate peaks in IR spectra (∼1,050 cm−1) and shifted NMR signals compared to non-phosphorylated Rapamycin. Analytical methods like LC-MS are essential to confirm the degree of phosphorylation and rule out degradation products.
Main Applications
In preclinical studies, phosphorylated Rapamycin demonstrates enhanced delivery to tumor tissues, making it valuable for investigating mTOR-dependent cancers. Researchers utilize it to study dose-response relationships where traditional Rapamycin formulations show inconsistent bioavailability. Another key application is in immunosuppression protocols for organ transplantation models. The modified compound's prolonged half-life allows for less frequent dosing in animal studies. Emerging uses include combination therapies with kinase inhibitors and nanoparticle-based delivery systems for precision medicine approaches.
Safety and Storage
As a biologically active compound, phosphorylated Rapamycin requires careful handling. Use fume hoods when weighing powder, and avoid skin contact (nitrile gloves recommended). SDS sheets classify it as a Category 3 irritant, with potential reproductive toxicity at high doses. Long-term storage demands airtight containers with desiccants, preferably under argon or nitrogen to prevent oxidation. Aliquot solutions in DMSO at -80°C for frequent use, avoiding freeze-thaw cycles. Dispose of waste through approved pharmaceutical incineration channels.
B2B Procurement Guide
When sourcing phosphorylated Rapamycin, prioritize suppliers providing: 1) Batch-specific COAs with HPLC purity ≥98%, 2) Mass spectrometry confirmation of molecular weight, and 3) Stability data under recommended storage conditions. Custom synthesis options are available for specific phosphorylation patterns. Bulk buyers (10g+) should negotiate stability guarantees and consider third-party testing. Lead times for GMP-grade material typically exceed 8 weeks. For research quantities, verify the supplier's expertise in phosphorylated compounds—specialized pharma intermediates manufacturers often outperform general chemical distributors in quality consistency.
Related Manufacturers
- 主营：科研试剂盒、酶免试剂盒、elisa试剂盒、生化试剂盒、细胞、生物试剂、进口ELISA试剂盒、PCR试剂盒、生化测试盒
- 主营：ELISA试剂盒、高灵敏度试剂盒、试剂盒厂家、羊ELISA试剂盒、人ELISA试剂盒、小鼠ELISA试剂盒、大鼠ELISA试剂盒、仓鼠ELISA试剂盒、豚鼠ELISA试剂盒、鸡ELISA试剂盒、鸭ELISA试剂盒、牛ELISA试剂盒、马ELISA试剂盒、猴ELISA试剂盒、猪ELISA试剂盒、犬ELISA试剂盒、兔ELISA试剂盒、鱼ELISA试剂盒、植物ELISA试剂盒、土壤ELISA试剂盒、定性ELISA试剂盒、肿瘤标志物检测ELISA试剂盒、特种蛋白检测ELISA试剂盒、传染病检测ELISA试剂盒
- 主营：氯霉素、糖蛋白、试剂盒、脂蛋白、胆固醇、钙蛋白、粘液素、调蛋白、磷酸酶、人嗅素、饥饿素、磷脂酶、抑制因、凝血酶、连接酶、凝集素、分泌酶、白介素、胰岛素、阻滞剂、结合盒、防御素、纤溶酶、干扰素、板层素
- 主营：ELISA试剂盒、抗体、细胞、磷酸化雷帕霉素靶蛋白、PCR试剂盒
- 主营：elisa试剂盒、生化试剂盒、pcr检测试剂盒、磷酸化雷帕霉素靶蛋白、细胞